Operating Income - HitGen Inc (SSE:688222) - Alpha Spread

HitGen Inc
SSE:688222

Watchlist Manager
HitGen Inc Logo
HitGen Inc
SSE:688222
Watchlist
Price: 8.47 CNY -1.05%
Market Cap: 3.4B CNY
Have any thoughts about
HitGen Inc?
Write Note

HitGen Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

HitGen Inc
Operating Income Peer Comparison

Comparables:
603259
300759
2269
300347
1548

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
HitGen Inc
SSE:688222
Operating Income
ÂĄ31.3m
CAGR 3-Years
-21%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Operating Income
ÂĄ10.6B
CAGR 3-Years
37%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Operating Income
ÂĄ1.6B
CAGR 3-Years
5%
CAGR 5-Years
25%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Operating Income
ÂĄ3.7B
CAGR 3-Years
9%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Operating Income
ÂĄ1.5B
CAGR 3-Years
13%
CAGR 5-Years
20%
CAGR 10-Years
30%
Genscript Biotech Corp
HKEX:1548
Operating Income
-$395m
CAGR 3-Years
-12%
CAGR 5-Years
-51%
CAGR 10-Years
N/A

See Also

What is HitGen Inc's Operating Income?
Operating Income
31.3m CNY

Based on the financial report for Dec 31, 2023, HitGen Inc's Operating Income amounts to 31.3m CNY.

What is HitGen Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-8%

The average annual Operating Income growth rates for HitGen Inc have been -21% over the past three years , -8% over the past five years .

Back to Top